Home > Drug Search >
  • company_query: Akashi Therapeutics
  •   > 
Drug Filter
Category:
chemistry (26) biology (4)
Status:
NDA Filing (1) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (15) Phase Ⅰ (6) IND Filing (3)
Clinical Stage:
Pending (7) Active (15) Discontinued (6)
Bio-Type:
Gene therapy (1) Whole antibody (2)
Indication:
Acne (1) Actinic keratosis (AK) (1) Allergic rhinitis (AR) (1) Alzheimer's disease (AD) (1) Breast cancer (1) Candidiasis (1) Delayed graft function (1) Duchenne muscular dystrophy (DMD) (2) Transplant rejection (1) HIV infection (5) Huntington's disease (1) Hypercholesterolemia (1) Leukemia (1) Malignancies (1) Non small cell lung cancer (NSCLC) (2) Haemolytic uraemic syndrome (1) Ovarian cancer (1) Prostate cancer (2) Rheumatoid arthritis (RA) (1) Schizophrenia (1) Smoking cessation (1) Solid tumours (3) Stable plaque psoriasis (1) Type 2 diabetes (1) Ulcerative colitis (2) Herpes labialis (1) Colon cancer (1) Neuroblastoma (1) Malignant glioma (1) Systemic inflammatory response syndrome (SIRS) (1) Hematological cancer (1) Mesothelioma (1) Skin hypertrophic scars (1) Metabolic Syndrome X (1) Cachexia (1) Opioid abuse (1) Shock (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top